Latest news with #outpatientcare
Yahoo
14-07-2025
- Health
- Yahoo
Family Care Center Brings Outpatient Mental Health Services to Memphis
Most insurance is accepted, and appointments for all ages are now available MEMPHIS, Tenn., July 14, 2025 /PRNewswire/ -- Family Care Center, a trusted leader in outpatient behavioral health, is proud to open its newest clinic in Memphis—marking its tenth location in Tennessee. This expansion underscores the organization's mission to provide accessible, high-quality mental health care where it's needed most. With Tennessee ranking 43rd in mental health access nationally, the need for timely, effective care is urgent. Long wait times, limited options for in-network care, and mental health provider shortages have made it difficult for many individuals and families to get the support they need. Family Care Center's Memphis clinic aims to close those gaps by offering fast access to appointments and a full range of outpatient mental health services that address anxiety, depression, trauma, and other mental conditions. "Opening our Memphis clinic reflects our ongoing commitment to expanding access to high-quality mental health care," said Dr. Chris Ivany, CEO of Family Care Center. "We provide personalized outpatient services for children, teens, and adults—supporting each individual with evidence-based treatment plans tailored to their unique needs. Our goal is to help every patient heal, grow, and thrive." The Family Care Center Memphis clinic offers a wide range of services, including: Individual, couples, and family therapy Children's and adolescent mental health care Military and Veterans' services Psychiatry and medication management Transcranial magnetic stimulation (TMS), an innovative, non-invasive procedure for treatment-resistant depression, anxiety, OCD, and other mental health conditions Future services will include a mental health intensive outpatient program (IOP) and psychoeducational testing. "Our goal is to meet the unique needs of the Memphis community by delivering care that respects every person's culture, language, and life experience," said State Director David Wood. "With a diverse team of expert clinicians and a welcoming, inclusive approach, we're making compassionate, effective mental health care accessible to everyone." The Memphis clinic accepts most major insurance plans in Tennessee, including Aetna, Cigna, Blue Cross Blue Shield, Tricare, and others, making high-quality care more accessible and affordable for all. To schedule an appointment or learn more about the Memphis clinic, visit or call (888) 374-5066. Family Care Center is a national leader in mental health services, dedicated to positively impacting the well-being of local communities. Their top-rated, multi-specialty clinicians deliver comprehensive, evidence-based care, providing positive outcomes for patients of all ages. In addition to therapy and psychiatric services, they are at the forefront of transcranial magnetic stimulation (TMS), an innovative treatment for depression and more. Family Care Center is one of the fastest-growing mental health care providers in the U.S, providing patient care, conducting research and offering continuing medical education in their field. With over 40 locations across Arizona, Colorado, Florida, Tennessee and Texas, they continue to expand nationally in collaboration with Revelstoke Capital Partners. View original content to download multimedia: SOURCE Family Care Center
Yahoo
08-07-2025
- Health
- Yahoo
First neighbourhood health services to be rolled out from September
The first neighbourhood health services will be rolled out in England's most deprived areas from September, the Government has said. Council bosses and local health chiefs have been urged to apply to join the first phase of the programme, which will bring tests, post-op care, mental health support and nursing teams closer to people's homes. The initiative is part of the Government's 10-year health plan, which was unveiled by Sir Keir Starmer last week. In his speech, the Prime Minister said the 'status quo of hospital by default will end', with the intention that the majority of outpatient care will happen outside of hospitals by 2035. Local councils and health chiefs have now been urged to apply to the programme by giving examples of innovation in their areas. Applicants will then join a national coaching programme, which will take place over the summer, with 42 sites beginning delivery of services from September. Priority will be given to deprived communities with the greatest need, according to the Department of Health and Social Care (DHSC), with staff focusing on patients with long-term conditions and complex needs. A joint taskforce has been set up by the DHSC and NHS England, chaired by Sir John Oldham, to drive progress. Health Secretary Wes Streeting said: 'Our 10-year health plan committed to building a neighbourhood health service, and we're hitting the ground running on delivering it. 'If we are to get patients cared for faster, on their doorstep and even in their own home, then we need to shift the focus of the NHS from hospitals to the community. 'Today, we are issuing an open invitation to local authorities and health services to become pioneer neighbourhood health services and lead the charge of healthcare reform. 'As part of our plan for change, we're beginning the neighbourhood health service in areas of greatest need first, to tackle the unfair health inequalities that blight our country.' The call comes weeks after Mr Streeting announced that around £2.2 billion previously set aside to plug financial holes will be spent on staff, medicines, new technology and equipment in rural communities, coastal towns and working class regions. The Government is also working on places to create neighbourhood health centres across the country. Eventually, these centres will be open 12 hours a day, six days a week, with teams comprising doctors, nurses, social care workers and pharmacists.
Yahoo
07-07-2025
- Business
- Yahoo
Morgan Stanley Maintains a Buy Rating on LifeStance Health (LFST), Keeps the PT at $10
LifeStance Health Group, Inc. (NASDAQ:LFST) is one of the 13 Stocks Under $5 With High Upside Potential. On May 27, Morgan Stanley analyst Craig Hettenbach maintained a Buy rating on LifeStance Health Group, Inc. (NASDAQ:LFST), keeping the associated price target the same at $10. The analyst based the rating on the company's growth potential and strategic positioning, stating that LifeStance Health Group, Inc. (NASDAQ:LFST) is well-positioned to capitalize on the rising demand for outpatient mental health services. A close-up of a healthcare professional studying a computer screen with data while consulting with a patient. This trend is driven by reduced social stigma regarding seeking behavioral health care, along with a shift to in-network insurance coverage. According to the analyst, LifeStance Health Group, Inc. (NASDAQ:LFST) has a hybrid care model that mixes in-person and virtual visits, supporting this demand through increasing flexibility for both clinicians and patients. The analyst further reasoned that LifeStance Health Group, Inc. (NASDAQ:LFST) is focusing on long-term EBITDA margin expansion, and management is confident about its potential to attain 15%-20% margins, up from the current guidance of around 10% by 2025. Hettenbach expects various factors to drive this margin expansion, including center margins improvements, slower growth in general and administrative expenses relative to revenue, and the introduction of higher-margin services. LifeStance Health Group, Inc. (NASDAQ:LFST) provides outpatient mental health services, including psychological and neuropsychological testing, psychiatric evaluations and treatment, and individual, family, and group therapy. The company operates through a mental health platform and also offers virtual care via its online delivery platform, as well as in-person care at centers located in 32 US states. While we acknowledge the potential of LFST as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
16-06-2025
- Business
- Yahoo
Outpatient & Specialty Care Stocks Q1 In Review: Select Medical (NYSE:SEM) Vs Peers
As the Q1 earnings season wraps, let's dig into this quarter's best and worst performers in the outpatient & specialty care industry, including Select Medical (NYSE:SEM) and its peers. The outpatient and specialty care industry delivers targeted medical services in non-hospital settings that are often cost-effective compared to inpatient alternatives. This means that they are more desired as rising healthcare costs and ways to combat them become more and more top-of-mind. Outpatient and specialty care providers boast revenue streams that are stable due to the recurring nature of treatment for chronic conditions and long-term patient relationships. However, their reliance on government reimbursement programs like Medicare means stroke-of-the-pen risk. Additionally, scaling a network of facilities can be capital-intensive with uneven return profiles amid competition from integrated healthcare systems. Looking ahead, the industry is positioned to grow as demand for outpatient services expands, driven by aging populations, a rising prevalence of chronic diseases, and a shift toward value-based care models. Tailwinds include advancements in medical technology that support more complex procedures in outpatient settings and the increasing focus on preventive care, which can be aided by data and AI. However, headwinds such as reimbursement rate cuts, labor shortages, and the financial strain of digitization may temper growth. The 7 outpatient & specialty care stocks we track reported a mixed Q1. As a group, revenues beat analysts' consensus estimates by 0.7% while next quarter's revenue guidance was 0.8% below. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 8.7% since the latest earnings results. With a nationwide network spanning 46 states and over 2,700 healthcare facilities, Select Medical (NYSE:SEM) operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers across the United States. Select Medical reported revenues of $1.35 billion, up 2.4% year on year. This print fell short of analysts' expectations by 2.6%. Overall, it was a softer quarter for the company with a significant miss of analysts' EPS estimates and full-year revenue guidance missing analysts' expectations. Select Medical delivered the weakest performance against analyst estimates and weakest full-year guidance update of the whole group. Unsurprisingly, the stock is down 16.4% since reporting and currently trades at $15.24. Read our full report on Select Medical here, it's free. With a nationwide footprint spanning 671 clinics across 42 states, U.S. Physical Therapy (NYSE:USPH) operates a network of outpatient physical therapy clinics and provides industrial injury prevention services to employers across the United States. U.S. Physical Therapy reported revenues of $183.8 million, up 18.1% year on year, outperforming analysts' expectations by 4.4%. The business had an exceptional quarter with an impressive beat of analysts' sales volume estimates and a decent beat of analysts' EPS estimates. U.S. Physical Therapy delivered the biggest analyst estimates beat and fastest revenue growth among its peers. The market seems happy with the results as the stock is up 8.6% since reporting. It currently trades at $77. Is now the time to buy U.S. Physical Therapy? Access our full analysis of the earnings results here, it's free. With over 2,600 dialysis centers across the United States and a presence in 13 countries, DaVita (NYSE:DVA) operates a network of dialysis centers providing treatment and care for patients with chronic kidney disease and end-stage kidney disease. DaVita reported revenues of $3.22 billion, up 5% year on year, exceeding analysts' expectations by 0.5%. Still, it was a slower quarter as it posted a significant miss of analysts' full-year EPS guidance estimates. As expected, the stock is down 5.5% since the results and currently trades at $136.12. Read our full analysis of DaVita's results here. With a network of 161 specialized facilities across 37 states and Puerto Rico, Encompass Health (NYSE:EHC) operates inpatient rehabilitation hospitals that help patients recover from strokes, hip fractures, and other debilitating conditions. Encompass Health reported revenues of $1.46 billion, up 10.6% year on year. This number beat analysts' expectations by 1.7%. It was a strong quarter as it also put up a solid beat of analysts' full-year EPS guidance estimates. Encompass Health delivered the highest full-year guidance raise among its peers. The stock is up 20.3% since reporting and currently trades at $122. Read our full, actionable report on Encompass Health here, it's free. Transforming how doctors care for seniors by shifting financial incentives from volume to outcomes, agilon health (NYSE:AGL) provides a platform that helps primary care physicians transition to value-based care models for Medicare patients through long-term partnerships and global capitation arrangements. agilon health reported revenues of $1.53 billion, down 4.5% year on year. This print topped analysts' expectations by 1.8%. Taking a step back, it was a decent quarter as revenue and EBITDA exceeded expectations. agilon health had the slowest revenue growth among its peers. The company lost 36,000 customers and ended up with a total of 491,000. The stock is down 51.2% since reporting and currently trades at $2.19. Read our full, actionable report on agilon health here, it's free. Thanks to the Fed's rate hikes in 2022 and 2023, inflation has been on a steady path downward, easing back toward that 2% sweet spot. Fortunately (miraculously to some), all this tightening didn't send the economy tumbling into a recession, so here we are, cautiously celebrating a soft landing. The cherry on top? Recent rate cuts (half a point in September 2024, a quarter in November) have propped up markets, especially after Trump's November win lit a fire under major indices and sent them to all-time highs. However, there's still plenty to ponder — tariffs, corporate tax cuts, and what 2025 might hold for the economy. Want to invest in winners with rock-solid fundamentals? Check out our Top 5 Growth Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
12-05-2025
- Health
- Medscape
More US Patients Choose Talk Therapy Over Psychotropics
Use of psychotherapy without medications increased among US outpatients between 2018 and 2021, while psychotropic medication–only treatment declined, new research showed. In addition, social workers and counselors assumed a larger role in mental health care as involvement of psychiatrists decreased. METHODOLOGY: Researchers analyzed data trends from four representative surveys of the US household population included in the 2018-2021 Medical Expenditure Panel Survey. They focused on nearly 18,000 adult outpatient mental health–related visits, including more than 6000 psychotherapy visits. Psychotherapy or counseling was defined broadly as treatment for specific mental health disorders, primarily involving talk-based interaction between the patient and a mental health professional. Participants received either psychotherapy alone, psychotropic medication alone, or both. The fully adjusted analysis controlled for age, sex, and psychological distress measured using the Kessler-6 scale. TAKEAWAY: From 2018 to 2021, the use of psychotherapy without medications by adults receiving outpatient mental health care increased significantly (fully adjusted difference, 2.8%; 95% CI, 0.6%-5.0%), but the use of psychotropic medication alone declined (fully adjusted difference, −3.4%; 95% CI, −6.2% to −0.7%). The mean number of psychotherapy visits per patient increased (adjusted difference, 2.1%; 95% CI, 0.6%-3.7%), with a significant increase noted among patients with mild or moderate distress. Social workers and mental health counselors provided psychotherapy to an increased proportion of patients (adjusted difference, 17.7%; 95% CI, 13.0%-22.5%), whereas the involvement of psychiatrists decreased (adjusted difference, −6.7%; 95% CI, −11% to −2.4%). Among patients receiving psychotherapy, treatment with anxiolytics/hypnotics decreased significantly (adjusted difference, −6.2%; 95% CI, −10% to −2.5%) as did treatment with antipsychotics (adjusted difference, −4.3%; 95% CI, −7.6% to −1%). IN PRACTICE: 'After years of American mental health care moving toward greater use of psychiatric medications, the pendulum has started swinging back toward are becoming more willing to seek out and stick with psychotherapy,' lead author Mark Olfson, MD, MPH, College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York City, said in a press release. SOURCE: The study was published online on May 1 in The American Journal of Psychiatry . LIMITATIONS: The study was limited by reliance on self-reported data, lack of diagnostic precision, and exclusion of important populations residing in institutional settings. It could not determine whether psychotherapy trends reflected changes in patients or practice. Additional limitations were the broad survey definition of psychotherapy, unmeasured treatment effectiveness, and lack of adjustment for multiple comparisons. DISCLOSURES: The investigators reported having no relevant conflicts of interest.
